Other secondary osteonecrosis, hand and fingers
ICD-10 M87.34 is a billable code used to indicate a diagnosis of other secondary osteonecrosis, hand and fingers.
M87.34 refers to a specific type of osteonecrosis that occurs in the hand and fingers, classified as secondary osteonecrosis. This condition arises when blood supply to the bone is disrupted, leading to bone tissue death. Secondary osteonecrosis can result from various factors, including trauma, corticosteroid use, alcohol abuse, and certain medical conditions such as sickle cell disease or systemic lupus erythematosus. In the hand and fingers, osteonecrosis can lead to significant pain, limited range of motion, and functional impairment. Patients may present with symptoms such as swelling, tenderness, and stiffness in the affected areas. Diagnosis typically involves imaging studies like X-rays or MRI to assess bone integrity and identify areas of necrosis. Treatment options may include conservative management with pain relief, physical therapy, or surgical interventions such as core decompression or joint replacement, depending on the severity of the condition. Accurate coding is essential for proper reimbursement and to reflect the complexity of the patient's condition.
Detailed history of the patient's condition, imaging results, and treatment plans.
Patients presenting with pain in the hand or fingers, particularly after trauma or corticosteroid use.
Ensure that the cause of osteonecrosis is clearly documented to support the use of M87.34.
Comprehensive assessment of systemic conditions contributing to osteonecrosis.
Patients with autoimmune diseases presenting with joint pain and potential osteonecrosis.
Document any relevant laboratory findings or disease activity indicators.
Used for pain management in osteonecrosis cases.
Document the joint involved, reason for the procedure, and any imaging studies.
Orthopedic specialists should ensure clear documentation of the patient's condition and treatment rationale.
Common causes include trauma, corticosteroid use, alcohol abuse, and systemic diseases such as lupus or sickle cell disease.
